Skip to content
IM Injection Allopathic

Protet-IG 250 IU/ml im injection

Generic: Human Tetanus Immunoglobulin

Company: Incepta Pharmaceuticals Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength250 IU/ml
PackNot listed yet

Reviewed by: not listed yet. Source: not listed yet.

Last updated September 7, 2024.

Compare

Same generic, same strength

Sorted by price per im injection. Ask your pharmacist before you switch brands.

Human Tetanus Immunoglobulin 250 IU/ml im injections

Prices as listed on BestinMeds.

No price is listed for this strength yet.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Human Tetanus Immunoglobulin guide

Indications

Tetanus Indications and uses Human Tetanus Immunoglobulin is indicated for - Prophylaxis of tetanus following injury in patients whose immunization is incomplete or uncertain. Therapeutically in the treatment of tetanus. Tetanus immunoglobulin should always be administered ... Read more Indications and uses Human Tetanus Immunoglobulin is indicated for - Prophylaxis of tetanus following injury in patients whose immunization is incomplete or uncertain. Therapeutically in the treatment of tetanus. Tetanus immunoglobulin should always be administered in conjunction with an active tetanus vaccination unless there are contraindications or confirmations of adequate vaccination.

Dosage and administration

Post-exposure prophylaxis of tetanus: For adults and children single dose of 250 IU should be given. The dose may be increased to 500 IU in case of: Infected wounds where surgically appropriate treatment cannot be achieved within 24 hours Deep or contaminated wounds with tissue damage and reduced oxygen supply, as well as foreign body injury (e.g., bites, stings or shots) Burns, congelations Tissue necrosis Septicaemic abortion Adults weighing more than the average In case of extensive bums, it is advisable to administer a second injection of 250 IU human tetanus immunoglobulin after the exsudative phase of the burn has subsided (about 36 hours after onset of the bum). At the same time, 0.5 ml of tetanus vaccine in a different extremity with a separate syringe and complete immunization schedule is required to be administered. Therapy of clinically manifest tetanus: For adults and children single doses of 3,000 to 6,000 IU (in combination with other appropriate clinical procedures).

Side effects

Adverse reaction following administration of human tetanus immunoglobulin is infrequent and mild, but severe local and systemic reactions have occurred rarely. Local reactions at the injection site: Local pain, tenderness or swelling. In rare cases the following adverse reactions may occur: Immune system disorders: Allergic reactions including fall in blood pressure, dyspnoea, cutaneous reactions, in isolated cases reaching as far as anaphylactic shock, even when the patient has shown no hypersensitivity to previous administration of immunoglobulins. Generalized reactions: Chills, fever, headache, malaise, nausea, vomiting, arthralgia and moderate back pain. Heart and vascular disorders: Cardiovascular reactions particularly if the product is inadvertently injected intravascularly.

Precautions and warnings

Should not be administered intravenously A separate sterile syringe must be used for each patient to prevent the possible transmission of hepatitis B and other infectious diseases. Should be administered with caution to individuals who have exhibited systemic allergic reactions to immunoglobulin. Epinephrine (0.1~0.5ml, 1:1000) should be available for immediate treatment. In patients who have severe thrombocytopenia or any coagulation disorder that would contra-indicated intramuscular injection, human tetanus immunoglobulin should be given only if the expected benefits out way the risks. While administering human tetanus immunoglobulin care should be taken to drawback the plunger of the syringe before injection in order to be certain that the needle is not in blood vessel. Human tetanus immunoglobulin is prepared from human plasma is pasteurized in its bulk condition to reduce the risk of viruses infections but freedom from the risk of unknown viruses (Parvovirus B-19, etc) cannot be assumed. The infused patient is continuously checked for long time after injection.

Pregnancy and lactation

The safety for use of human tetanus immunoglobulin in human pregnancy has not been established in controlled clinical trials. Long lasting clinical experience with immunoglobulins suggests that no harmful effects on the course of pregnancy, or on the fetus and the neonate are to be expected.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250